Gene · 970
Papers4,349
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1,181 to 1,200 of 4,349
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Single-Cell Transcriptome Analysis Reveals Different Immune Signatures in HPV- and HPV + Driven Human Head and Neck Squamous Cell Carcinoma. | J Immunol Res | 2022 | 36157879 | PubTator, text mining | PubMed |
| Recent findings on chimeric antigen receptor (CAR)-engineered immune cell therapy in solid tumors and hematological malignancies. | Stem Cell Res Ther | 2022 | 36153626 | PubTator, text mining | PubMed |
| Novel cellular immunotherapies for hematological malignancies: recent updates from the 2021 ASH annual meeting. | Exp Hematol Oncol | 2022 | 36153595 | PubTator, text mining | PubMed |
| Over-expression of NFYB affects stromal cells reprogramming and predicts worse survival in gastric cancer patients. | Aging (Albany NY) | 2022 | 36152055 | PubTator, text mining | PubMed |
| The role of virus infections in Sjögren's syndrome. | Front Immunol | 2022 | 36148238 | PubTator, text mining | PubMed |
| PLXDC1 Can Be a Biomarker for Poor Prognosis and Immune Evasion in Gastric Cancer. | J Inflamm Res | 2022 | 36147688 | PubTator, text mining | PubMed |
| Co-Infection and Cancer: Host-Pathogen Interaction between Dendritic Cells and HIV-1, HTLV-1, and Other Oncogenic Viruses. | Viruses | 2022 | 36146843 | PubTator, text mining | PubMed |
| Heterogenous CD8+ T Cell Maturation and 'Polarization' in Acute and Convalescent COVID-19 Patients. | Viruses | 2022 | 36146713 | PubTator, text mining | PubMed |
| Recent Advances in Glioma Cancer Treatment: Conventional and Epigenetic Realms. | Vaccines (Basel) | 2022 | 36146527 | PubTator, text mining | PubMed |
| Mitochondrial Aldehyde Dehydrogenase 2 Represents a Potential Biomarker of Biochemical Recurrence in Prostate Cancer Patients. | Molecules | 2022 | 36144737 | PubTator, text mining | PubMed |
| Molecular and Cellular Mechanisms of Propolis and Its Polyphenolic Compounds against Cancer. | Int J Mol Sci | 2022 | 36142391 | PubTator, text mining | PubMed |
| Identification of Key Genes and Pathways in Genotoxic Stress Induced Endothelial Dysfunction: Results of Whole Transcriptome Sequencing. | Biomedicines | 2022 | 36140167 | PubTator, text mining | PubMed |
| Systematic Analysis of Genetic and Pathway Determinants of Eribulin Sensitivity across 100 Human Cancer Cell Lines from the Cancer Cell Line Encyclopedia (CCLE). | Cancers (Basel) | 2022 | 36139690 | PubTator, text mining | PubMed |
| Cancer-Associated Fibroblasts: The Origin, Biological Characteristics and Role in Cancer-A Glance on Colorectal Cancer. | Cancers (Basel) | 2022 | 36139552 | PubTator, text mining | PubMed |
| Co-Stimulatory Receptor Signaling in CAR-T Cells. | Biomolecules | 2022 | 36139142 | PubTator, text mining | PubMed |
| Research Progress on Nanoparticles-Based CRISPR/Cas9 System for Targeted Therapy of Tumors. | Biomolecules | 2022 | 36139078 | PubTator, text mining | PubMed |
| Specific transcriptional programs differentiate ICOS from CD28 costimulatory signaling in human Naïve CD4+ T cells. | Front Immunol | 2022 | 36131938 | PubTator, text mining | PubMed |
| Deciphering the endometrial immune landscape of RIF during the window of implantation from cellular senescence by integrated bioinformatics analysis and machine learning. | Front Immunol | 2022 | 36131919 | PubTator, text mining | PubMed |
| CAR-T cell potency: from structural elements to vector backbone components. | Biomark Res | 2022 | 36123710 | PubTator, text mining | PubMed |
| Therapeutic targets and biomarkers of tumor immunotherapy: response versus non-response. | Signal Transduct Target Ther | 2022 | 36123348 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/970/papers?page=60